Filing metadata

Accession number
0001415889-25-003618
Form type
Form 4
Filer
Quince Therapeutics, Inc.
CIK
CIK 1662774
Filed
Feb 11, 2025
Reporting period
Jan 28, 2025
Description
Insider transaction

Explore SEC Filings Hub